Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16
Published February 12, 2025 · Recall initiated: January 7, 2025
Summary
FDA records drug Class III recall D-0222-2025, published February 12, 2025 and initiated January 7, 2025. Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 4080 Bottles; Lot: Lot number 4B07, Exp Date: 2026-OCT-31. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent; sodium benzoate preservative
What to do
Voluntary: Firm initiated · Letter
Get an email if GUAIFENESIN AND CODEINE PHOSPHATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- GUAIFENESIN AND CODEINE PHOSPHATE
- Manufacturer
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc
- Distributor
- OH
- Lot
- Lot number 4B07, Exp Date: 2026-OCT-31
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPotassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit doseFebruary 12, 2025
- FDAAdrenalin Chloride Solution (Epinephrine Nasal Solution, USP), 30mg/30mL (1mg/mL), packaged in 30 mL vials,February 12, 2025
- FDAHydrALAZINE Hydrochloride, 100 Tablets (10x10), USP, 50mg, Rx only, Manufactured by Strides Pharma ScienceFebruary 12, 2025
- FDAMonkey Spit "Swamp Mop" BBQ Sauce, 12 fl oz (355ml) glass bottle, 12 bottles/case; Refrigerate after opening;February 12, 2025
- FDAHydrALAZINE Hydrochloride, 25 mg, 100 Unit Dose Tablets (10x10), USP, Rx only, Manufactured by Strides PharmaFebruary 12, 2025
- FDAMonkey Spit "Atomic Mop" BBQ Sauce, 12 fl oz (355ml) glass bottle, 12 bottles/case; Refrigerate after opening;February 12, 2025
Questions about this recall
Was Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16 recalled?
Yes. FDA published recall D-0222-2025 on February 12, 2025. Reported hazard: Superpotent; sodium benzoate preservative
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: GUAIFENESIN AND CODEINE PHOSPHATE.